Detail of the GeneXpert machine being used to test a sample of suspected Tuberculosis in the lab at Bangassou Hospital.
Press release |

Delays in supply of the critical GeneXpert TB test are unacceptable. Now more than ever, we need a doubling down on urgent actions to help countries scale up lifesaving TB testing.

Read more
Photograph by Borja Ruiz Rodriguez

Work you can support right now!

Prepare for the Future

Currently, many low- and middle-income countries (LMICs) are almost entirely dependent on imports and donations of COVID and other vaccines, contributing to vaccine inequity.  

If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.

How you can support

What good is a breakthrough medicine if the people who need it can't afford it?